Cargando…
Loureirin B downregulates osteoclast differentiation of bone marrow macrophages by targeting the MAPK signaling pathway
Excessive absorption of osteoclasts will break the balance between osteoclasts and osteoblasts, leading to bone loss, decreased bone density, and increased bone fragility. We have shown that Loureirin B (LrB) can inhibit osteoclasts. In this study, we demonstrated the targeting-inhibitory mechanism...
Autores principales: | Zhang, Jiahao, Mo, Liang, Huang, Haoran, Xu, Jiake, Fan, Yinuo, Li, Weifeng, Wang, Haibin, Zhou, Chi, Fang, Hanjun, He, Wei, Chen, Zhenqiu, Liu, Yuhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399088/ https://www.ncbi.nlm.nih.gov/pubmed/35999378 http://dx.doi.org/10.1038/s41598-022-18287-5 |
Ejemplares similares
-
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
por: Liu, Yuhao, et al.
Publicado: (2019) -
Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways
por: Liu, Yuhao, et al.
Publicado: (2023) -
Clinical Outcome of Surgical Hip Dislocation Combined with Impacting Bone Grafts and Implanting Iliac Bone Flaps in the Treatment of Osteonecrosis of the Femoral Head: A Mid‐term Retrospective Study
por: Zhou, Chi, et al.
Publicado: (2022) -
Evaluation of the predictive values of collapse and necrotic lesion boundary for osteonecrosis of the femoral head prognosis
por: Fan, Yinuo, et al.
Publicado: (2023) -
Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity
por: Deng, Wei, et al.
Publicado: (2022)